These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

329 related items for PubMed ID: 21475778

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Optimal duration of anticoagulation of venous thromboembolism].
    Savina EN, Couturaud F.
    J Mal Vasc; 2011 Dec; 36 Suppl 1():S28-32. PubMed ID: 22177766
    [Abstract] [Full Text] [Related]

  • 5. Venous thromboembolism in patients with cancer: an overview for pharmacists using a case-based approach.
    Pangilinan JM.
    J Pharm Pract; 2010 Aug; 23(4):294-302. PubMed ID: 21507829
    [Abstract] [Full Text] [Related]

  • 6. Unprovoked venous thromboembolism: Short term or indefinite anticoagulation? Balancing long-term risk and benefit.
    Rodger M, Carrier M, Gandara E, Le Gal G.
    Blood Rev; 2010 Aug; 24(4-5):171-8. PubMed ID: 20633967
    [Abstract] [Full Text] [Related]

  • 7. Long-term anticoagulation for venous thromboembolism: duration of treatment and management of warfarin therapy.
    Kearon C.
    Clin Chest Med; 2010 Dec; 31(4):719-30. PubMed ID: 21047578
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The optimal duration of anticoagulation in patients with venous thromboembolism: how long is long enough?
    Prandoni P, Piovella C, Spiezia L, Dalla Valle F, Pesavento R.
    Panminerva Med; 2012 Mar; 54(1):39-44. PubMed ID: 22278115
    [Abstract] [Full Text] [Related]

  • 10. Anticoagulation therapy for prevention and treatment of venous thromboembolic events in cancer patients: a review of current guidelines.
    Petersen LJ.
    Cancer Treat Rev; 2009 Dec; 35(8):754-64. PubMed ID: 19762155
    [Abstract] [Full Text] [Related]

  • 11. Rivaroxaban for the treatment of venous thromboembolism. The SWIss Venous ThromboEmbolism Registry (SWIVTER).
    Kucher N, Aujesky D, Beer JH, Mazzolai L, Baldi T, Banyai M, Hayoz D, Kaeslin T, Korte W, Escher R, Husmann M, Frauchiger B, Baumgartner I, Spirk D.
    Thromb Haemost; 2016 Aug 30; 116(3):472-9. PubMed ID: 27346301
    [Abstract] [Full Text] [Related]

  • 12. Periprocedural anticoagulation management of patients with venous thromboembolism.
    McBane RD, Wysokinski WE, Daniels PR, Litin SC, Slusser J, Hodge DO, Dowling NF, Heit JA.
    Arterioscler Thromb Vasc Biol; 2010 Mar 30; 30(3):442-8. PubMed ID: 20139361
    [Abstract] [Full Text] [Related]

  • 13. Elevated white blood cell count and outcome in cancer patients with venous thromboembolism. Findings from the RIETE Registry.
    Trujillo-Santos J, Di Micco P, Iannuzzo M, Lecumberri R, Guijarro R, Madridano O, Monreal M, RIETE Investigators.
    Thromb Haemost; 2008 Nov 30; 100(5):905-11. PubMed ID: 18989537
    [Abstract] [Full Text] [Related]

  • 14. Venous thromboembolism in patients with advanced cancer under palliative care: additional risk factors, primary/secondary prophylaxis and complications observed under normal clinical practice.
    Soto-Cárdenas MJ, Pelayo-García G, Rodríguez-Camacho A, Segura-Fernández E, Mogollo-Galván A, Giron-Gonzalez JA.
    Palliat Med; 2008 Dec 30; 22(8):965-8. PubMed ID: 18952751
    [Abstract] [Full Text] [Related]

  • 15. Inflammatory bowel disease is a risk factor for recurrent venous thromboembolism.
    Novacek G, Weltermann A, Sobala A, Tilg H, Petritsch W, Reinisch W, Mayer A, Haas T, Kaser A, Feichtenschlager T, Fuchssteiner H, Knoflach P, Vogelsang H, Miehsler W, Platzer R, Tillinger W, Jaritz B, Schmid A, Blaha B, Dejaco C, Eichinger S.
    Gastroenterology; 2010 Sep 30; 139(3):779-87, 787.e1. PubMed ID: 20546736
    [Abstract] [Full Text] [Related]

  • 16. Treatment and secondary prevention of venous thromboembolism in cancer patients. Current strategies and new therapeutic options.
    Ay C, Pabinger I.
    Hamostaseologie; 2012 Sep 30; 32(2):139-44. PubMed ID: 21822525
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The treatment of venous thromboembolism in patients with cancer.
    Prandoni P.
    Intern Emerg Med; 2010 Oct 30; 5 Suppl 1():S27-30. PubMed ID: 20865471
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.